• Join
  • Login
  • Contact

Search abstracts / presentations

Comparison of the world health organization model essential medicines list and twenty-five national essential medicines lists: what can developing countries and the world health organization learn from one another about selection of medicines?

  • In: Post-Marketing innovation in Drug Development (SIG Pharmacoeconomics/Pharmacoepidemiology and Industrial Pharmacy Section) on Tuesday, 7 September 2004, 14:00-17:00
  • At: New Orleans (USA) (2004)
  • Type: Presentation
  • By: WANING, Brenda (Boston University, Center for Internationql Health, Boston, United States of America)
  • Abstract:

    Aims: Evaluate the process of creating Essential Medicines Lists (EMLs) by the Expert Committee at the World Health Organization (WHO) and national selection committees in developing countries to identify trends, research priorities, and areas of improvement inselection of medicines. Methods: All WHO Model EMLs from 1977-2003 were


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses